COMMUNIQUÉS West-GlobeNewswire

Resonant Inc. to Present at the 21st Annual Needham Growth Conference
04/01/2019
GOLETA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]
BioCryst Appoints Steve Aselage to Board of Directors
04/01/2019
RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed Steve Aselage to its board of directors. Mr. Aselage most [...]
Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board
04/01/2019
CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease
04/01/2019
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Jan. 04, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced that the U.S. Food and Drug [...]
Dr. Henry Ji to Participate In Financing Expert Panel at East/West CEO Conference
04/01/2019
SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today that Dr. Henry Ji, Chairman and CEO, will participate in the East/West CEO conference in San Francisco [...]
Mersana Therapeutics Announces Strategic Priorities and Goals for 2019 and Beyond
04/01/2019
Company to Focus its Resources on Advancing XMT-1536, its First-in-Class ADC Candidate Targeting NaPi2b, Showing Encouraging Early Signs of Efficacy Dose Selection and Initiation of XMT-1536 Expansion Cohorts on Track [...]
Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO™ to Treat Complicated Urinary Tract Infections by FDA
04/01/2019
-PDUFA action date set for June 30, 2019- DUBLIN, Ireland, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of [...]
Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEO
04/01/2019
GAITHERSBURG, Md., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its CEO Daniel J. Abdun-Nabi will be retiring and that its board of directors has unanimously appointed [...]
OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance
04/01/2019
CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics Novosanis’ urine collection technology expands [...]
Vistin Pharma ASA : Trading update for Energy Trading
04/01/2019
Oslo, Norway, 4 January 2019 Reference is made to the announcement yesterday regarding the resignation of Torbjørn Kjus, Head of Energy Trading at Vistin Pharma ASA ("Vistin Pharma" or the "Company"). The Company is in [...]
Zealand Pharma to attend JP Morgan Healthcare Conference and Oddo BHF Forum
04/01/2019
Press release – No. 2 / 2019 Zealand Pharma to attend JP Morgan Healthcare Conference and Oddo BHF Forum Copenhagen, January 4, 2019 – Britt Meelby Jensen, President and Chief Executive Officer of Zealand Pharma, Mats [...]
Evelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology Indications
04/01/2019
-- Initial Clinical Data Expected in First Half of 2020 -- CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (NASDAQ:EVLO) (“Evelo”) a biotechnology company developing monoclonal microbials, a [...]
Eckert & Ziegler BEBIG: Meeting Minutes Extraordinary General Meeting
04/01/2019
Seneffe, January 4, 2019. The Minutes and all relevant documents regarding the Extraordinary General Assembly 2018 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About [...]
Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale extraordinaire des actionnaires
04/01/2019
Seneffe, le 4 janvier 2019. Le procès verbal ainsi que tous les documents relatifs à l'assemblé générale extraordinaire 2018 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/ [...]
Zealand Pharma completes equity investment in strategic partner Beta Bionics
04/01/2019
Press release – No. 1 / 2019 Zealand Pharma completes equity investment in strategic partner Beta Bionics Zealand Pharma invests USD 3.5 million in the final close of strategic partner Beta Bionics’ series B financing [...]
Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients
04/01/2019
Orion Corporation Press release 4 January 2019 at 9.00 a.m. Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients Orion Corporation, a [...]
ASLAN Pharmaceuticals Announces IND Submission for ASLAN003 to U.S. FDA and Conclusion of 30-Day Review Period
04/01/2019
- ASLAN003 is an orally active, potent inhibitor of DHODH that has the potential to be first-in-class in AML - Positive interim Phase 2a data for ASLAN003 in AML was presented at the 2018 ASH Annual Meeting SINGAPORE, [...]
VYZULTA Approved in Canada by Nicox's Partner
04/01/2019
Press Release VYZULTA Approved in Canada by Nicox's Partner ............................................... January 4, 2019 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX [...]
VYZULTA approuvé au Canada par le partenaire licencié de Nicox
04/01/2019
Communiqué de presse VYZULTA TM approuvé au Canada par le partenaire licencié de Nicox ................................................. 4 janvier 2019 - diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]

Pages